Used in biomedical research to measure fructosamine levels in rat blood samples, this ELISA kit helps assess intermediate to long-term glycemic control in experimental models of diabetes. It is particularly useful in studies evaluating the effectiveness of antidiabetic drugs, dietary interventions, or metabolic therapies. By measuring glycated proteins, researchers can monitor glucose fluctuations over time, providing a more stable indicator than single-point blood glucose tests. The kit supports high-throughput screening and is commonly used in preclinical studies, metabolic disease research, and pharmaceutical development.